{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:10:26Z","timestamp":1787069426253,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002977","name":"Dalhousie University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005785","name":"Dalhousie University Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012285","name":"BC Children's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012285","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008572","name":"University of Ottawa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008572","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004073","name":"Killam Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004073","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000032","name":"Institute of Infection and Immunity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000032","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.vaccine.2025.127254","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T16:53:44Z","timestamp":1747760024000},"page":"127254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Neurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network"],"prefix":"10.1016","volume":"59","author":[{"given":"Tiffany","family":"Fitzpatrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Yamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Summerby-Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthaporn","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sadarangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Belga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Carignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina A.","family":"Top","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127254_bb0005","series-title":"COVID-19 vaccine. Canadian Immunization Guide","author":"National Advisory Committee on Immunization","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127254_bb0010","series-title":"COVID-19 vaccine safety in Canada","author":"Public Health Agency of Canada","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127254_bb0015","series-title":"COVID-19 AESI list 5th update \u2013 October 2022","author":"Safety Platform for Emergency Vaccines","year":"2022"},{"key":"10.1016\/j.vaccine.2025.127254_bb0020","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2025.127254_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53845","article-title":"Reports of Guillain-Barr\u00e9 syndrome after COVID-19 vaccination in the United States","volume":"6","author":"Abara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.127254_bb0030","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2024.01.100","article-title":"COVID-19 vaccines and adverse events of special interest: a multinational global vaccine data network (GVDN) cohort study of 99 million vaccinated individuals","volume":"42","author":"Faksova","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127254_bb0035","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.26339","article-title":"Neurological events reported after COVID-19 vaccines: an analysis of VAERS","volume":"91","author":"Frontera","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2025.127254_bb0040","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1016\/j.vaccine.2021.10.058","article-title":"Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: a case-control study","volume":"39","author":"Garcia-Grimshaw","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127254_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/14740338.2022.2120607","article-title":"Disproportionality analysis of adverse neurological and psychiatric reactions with the ChAdOx1 (Oxford-AstraZeneca) and BNT162b2 (Pfizer-BioNTech) COVID-19 vaccines in the United Kingdom","volume":"22","author":"Otero-Losada","year":"2023","journal-title":"Expert Opin Drug Saf"},{"issue":"45\u201353","key":"10.1016\/j.vaccine.2025.127254_bb0050","article-title":"Revaccination and adverse event recurrence in patients with adverse events following immunization","volume":"250","author":"Munoz","year":"2022","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2025.127254_bb0055","series-title":"COVID-19 vaccination in Canada","author":"Public Health Agency of Canada","year":"2024"},{"key":"10.1016\/j.vaccine.2025.127254_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.14745\/ccdr.v40is3a02","article-title":"Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012","volume":"40","author":"Law","year":"2014","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2025.127254_bb0065","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127254_bb0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127254_bb0075","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.vaccine.2016.05.023","article-title":"Facial nerve palsy including Bell\u2019s palsy: case definitions and guidelines for collection, analysis, and presentation of immunisation safety data","volume":"35","author":"Rath","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127254_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jocn.2022.12.015","article-title":"Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences Centre and review of the literature","volume":"108","author":"Samim","year":"2023","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.vaccine.2025.127254_bb0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamaoto.2023.0160","article-title":"Association of SARS-CoV-2 vaccination or infection with Bell palsy: a systematic review and Meta-analysis","volume":"149","author":"Rafati","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.vaccine.2025.127254_bb0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/qjmed\/hcac251","article-title":"Low incidence of neurological recurrent side-effects following COVID-19 reimmunization","volume":"116","author":"Koh","year":"2023","journal-title":"QJM"},{"key":"10.1016\/j.vaccine.2025.127254_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/INF.0000000000002162","article-title":"Rate of recurrence of adverse events following immunization: results of 19 years of surveillance in Quebec, Canada","volume":"38","author":"Zafack","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2025.127254_bb0100","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.vaccine.2023.08.067","article-title":"Factors associated with intention for revaccination among patients with adverse events following immunization","volume":"41","author":"Munoz","year":"2023","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127254_bb0105","article-title":"An overview of strategies to improve vaccination compliance before and during the COVID-19 pandemic","volume":"3","author":"Charrier","year":"2022","journal-title":"Int J Environ Res Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25005511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25005511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:42:20Z","timestamp":1762278140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25005511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":21,"alternative-id":["S0264410X25005511"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127254","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurological adverse events following COVID-19 vaccination among Canadians referred to the special immunization clinic network","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127254"}}